Directed differentiation of regulatory T cells from naive T cells and prevention of their inflammation‐mediated instability using small molecules by Haddadi, M.‐H., Negahdari, B., Hajizadeh‐Saffar, E., Khosravi‐Maharlooei, M., Basiri, M., Dabiri, H., Baharvand, H.

Get full text

Inducible VEGF Expression by Human Embryonic Stem Cell-Derived Mesenchymal Stromal Cells Reduces the Minimal Islet Mass Required to Reverse Diabetes by Hajizadeh-Saffar, E., Tahamtani, Y., Aghdami, N., Azadmanesh, K., Habibi-Anbouhi, M., Heremans, Y., De Leu, N., Heimberg, H., Ravassard, P., Shokrgozar, M. A., Baharvand, H.

Get full text

Optimization of gmp-compatible biobanking of allogeneic bone marrow-derived clonal mesenchymal stromal cells for cell therapy applications by Pakzad, M., Abbasi, F., Samadian, A., Hajizadeh Saffar, E., Hassani, S., Baharvand, H.

Get full text

Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic Strategies by Ramezankhani, Roya, Torabi, Shukoofeh, Minaei, Neda, Madani, Hoda, Rezaeiani, Siamak, Hassani, Seyedeh Nafiseh, Gee, Adrian P, Dominici, Massimo, Silva, Daniela Nascimento, Baharvand, Hossein, Hajizadeh-Saffar, Ensiyeh

Get full text

Characterizations of molecularly distinct subpopulations of conditioned medium derived extracellular vesicles prior to be used as medicinal product by Sheakri, F., Assar, S., Amini, A., Saffar, E. Hajizadeh, Nazari, A., Baharvand, H.

Get full text

Mesenchymal Stem Cells Transplantation in newly diagnosed type-1 diabetes patients:a phase I/II Randomized Controlled trial by Izadi, M., Nejad, A. Sadr Hashemi, Moazenchi, M., Rabbani, A., Kompani, F., Asl, A. Hedayati, Abbasi, F., Jaroughi, N., Meybodi, M. Mohseni, Masoumi, S., Hosseini, E., Setoodeh, A., Abbasi, F., Navabi, R., Saffar, E. Hajizadeh, Baharvand, H.

Get full text